The global hospital infection therapeutics market is expected to reach $3.6 billion by 2020.
Here are five things to know:
1. The market stood at $3 billion in 2013.
2. From 2014 to 2020, market is expected to grow at a CAGR of 3.1 percent.
3. The increasing prevalence of HAIs, rising aging population, demand for better therapeutic drugs and growing healthcare awareness are driving the market's growth.
4. Rising surveillance programs and increased infection control measures may hinder the market's growth.
5. North America currently leads the market, followed by Europe. Asia-Pacific is the fastest growing regional segment in the market due to its rising prevalence of HAIs in the area.
More articles on quality & infection control:
Communication errors result in deaths, costly malpractice suits — 6 insights
California pays insurers for new hepatitis C drugs — 5 notes
Patients may be more likely to receive unnecessary blood tests before low-risk procedures: 5 highlights
